Comparative studies with exendin(9-39)amide and the novel (Pro3)GIP receptor antagonist indicates that glucose-dependent insulinotropic polypeptide is the major hormone of the enteroinsular axis.

F.P.M. O'Harte, V.A. Gault, Patrick Harriott, Brian Green, P.R. Flatt

Research output: Contribution to journalMeeting abstract

Original languageEnglish
Article numberA178
JournalDiabetologia
Volume45
Issue numberS2
Publication statusPublished - 2002

Cite this